These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 459087)

  • 1. [Studies on cefmetazole concentration in human biliary tract and clinical effect for acute or subacute cholecystitis (author's transl)].
    Kasai Y; Nakanishi M; Sawada Y; Nakamura T; Hashimoto I; Mikami J; Sahashi Y
    Jpn J Antibiot; 1979 May; 32(5):606-11. PubMed ID: 459087
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)].
    Hirasawa S; Abe H; Bekki E; Hashimoto I; Sawada Y; Nakamura T; Mikami J; Watanabe Y
    Jpn J Antibiot; 1980 Dec; 33(12):1294-300. PubMed ID: 6454012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on cefotaxime (HR 756) concentration in human biliary tract and clinical effect for acute or subacute cholecystitis with cholelithiasis (author's transl)].
    Kasai Y; Nakanishi M; Sawada Y; Nakamura T; Hashimoto I; Mikami J; Bekki E; Hirasawa S; Abe H; Kasai K; Omosu M
    Jpn J Antibiot; 1981 Mar; 34(3):447-52. PubMed ID: 6270392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies on 6059-S for biliary tract diseases. Clinical effect and tissue concentration (author's transl)].
    Abe H; Hirasawa S; Bekki E; Sawada Y; Hashimoto I; Nakamura T; Mikami J; Katoh H; Matsuda S
    Jpn J Antibiot; 1981 Apr; 34(4):631-40. PubMed ID: 6457172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative biliary concentrations of cephazolin and cephalothin in patients with biliary tract disease.
    Madhavan T; Block M; Quinn EL; Cox F; Fisher EJ; Burch KH; Haas EJ
    Scott Med J; 1976 Sep; 20(5):255-8. PubMed ID: 1265475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experiences with cefmetazole for peritonitis and biliary tract infections with special reference to excretion of cefmetazole into bile (author's transl)].
    Saito T; Yamada Y; Yokoyama S
    Jpn J Antibiot; 1979 Apr; 32(4):504-8. PubMed ID: 459081
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical studies of cefmetazole (author's transl)].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E
    Jpn J Antibiot; 1979 Mar; 32(3):335-8. PubMed ID: 439402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary excretion and concentration of cefazolin.
    Ram MD; Watanatittan S
    Am J Gastroenterol; 1976 Dec; 66(6):540-5. PubMed ID: 1020741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on absorption and excretion of cefmetazole in neonates and excretion into the bile of infants with congenital biliary atresia (author's transl)].
    Yura J; Tsuruga N; Hayashi S
    Jpn J Antibiot; 1981 Jun; 34(6):903-6. PubMed ID: 6945450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in the ultracentrifugal characteristics of human gallbldder and hepatic bile with diseases of the biliary tree.
    El Kodsi B; Cooperband SR; Bouchier IA
    J Lab Clin Med; 1968 Oct; 72(4):592-601. PubMed ID: 5677307
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic excretion into the bile after hepatic-portojejunostomy in biliary atresia.
    Miyano T; Suruga K; Arai T; Nittono H; Kato H
    J Pediatr Surg; 1983 Feb; 18(1):42-6. PubMed ID: 6220141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gentamicin levels in the human biliary tract.
    Pitt HA; Roberts RB; Johnson WD
    J Infect Dis; 1973 Mar; 127(3):299-302. PubMed ID: 4688926
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with cefmetazole (author's transl)].
    Saito T
    Jpn J Antibiot; 1979 May; 32(5):612-3. PubMed ID: 459088
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mucoid substances of the bile in biliary tract diseases].
    Sheleketina II; Leliukhina EV
    Vrach Delo; 1974 Aug; 0(8):39-43. PubMed ID: 4277883
    [No Abstract]   [Full Text] [Related]  

  • 15. [Massive cefmetazole (CS-1170) therapy for extremely severe respiratory infections (author's transl)].
    Isawa T; Teshima T; Hirano T; Ebina A; Konno K
    Jpn J Antibiot; 1980 Aug; 33(8):758-66. PubMed ID: 6937692
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience of treatment of purulent osteomyelitis with cefmetazole (author's transl)].
    Kawashima M; Tamura H
    Jpn J Antibiot; 1982 Mar; 35(3):840-4. PubMed ID: 6954291
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience of therapeutic use of cefmetazole (cefmetazon) or bronchopneumonia (author's transl)].
    Murao M; Terai T; Kirisawa T; Kon H; Moriyama Y; Hattori T
    Jpn J Antibiot; 1981 Jun; 34(6):856-63. PubMed ID: 6945446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The concentration of latamoxef achieved in the bile and gallbladder wall of patients with cholecystitis.
    Vowden P; Stewart J; Fowler B; Ramsden CH; Kester RC
    J Antimicrob Chemother; 1986 Aug; 18(2):227-32. PubMed ID: 3759734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Profile of cefmetazole. Report III. In the field of internal medicine (author's transl)].
    Hara K
    Kansenshogaku Zasshi; 1979 Feb; 53(2):75-81. PubMed ID: 115938
    [No Abstract]   [Full Text] [Related]  

  • 20. [Profile of cefmetazole. Report V. In the field of urology (author's transl)].
    Ishigami J
    Kansenshogaku Zasshi; 1979 Feb; 53(2):87-97. PubMed ID: 115940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.